Allovir IncNASDAQ:ALVRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.9300
- TODAY'S CHANGE (%)0.0440 (4.9661%)
- Bid / Lots0.9058/ 6
- Ask / Lots0.9200/ 6
- Open / Previous Close0.8710 / 0.8860
- Day Range
- 52 Week Range
- Volume589,138
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALVR |
|---|---|---|
| 09:32 ET | 1080 | 0.871 |
| 09:43 ET | 112 | 0.8702 |
| 09:45 ET | 1014 | 0.87 |
| 09:52 ET | 100 | 0.87575 |
| 09:56 ET | 12878 | 0.8575 |
| 09:57 ET | 2600 | 0.875901 |
| 09:59 ET | 4393 | 0.8795 |
| 10:01 ET | 500 | 0.87575 |
| 10:08 ET | 100 | 0.8531 |
| 10:12 ET | 1000 | 0.87575 |
| 10:14 ET | 2399 | 0.8879 |
| 10:15 ET | 1642 | 0.905 |
| 10:17 ET | 3800 | 0.919 |
| 10:19 ET | 13700 | 0.9188 |
| 10:21 ET | 5900 | 0.9146 |
| 10:24 ET | 8632 | 0.915 |
| 10:26 ET | 2800 | 0.90155 |
| 10:28 ET | 700 | 0.89965 |
| 10:30 ET | 300 | 0.89965 |
| 10:32 ET | 100 | 0.89965 |
| 10:33 ET | 100 | 0.89965 |
| 10:35 ET | 200 | 0.89965 |
| 10:37 ET | 1598 | 0.9197 |
| 10:39 ET | 2100 | 0.9162 |
| 10:44 ET | 12370 | 0.9041 |
| 10:46 ET | 1200 | 0.9282 |
| 10:48 ET | 300 | 0.916525 |
| 10:50 ET | 100 | 0.9051 |
| 10:51 ET | 2703 | 0.91755 |
| 10:53 ET | 5000 | 0.93 |
| 10:55 ET | 2500 | 0.9076 |
| 10:57 ET | 2950 | 0.92155 |
| 11:00 ET | 7801 | 0.9327 |
| 11:02 ET | 3400 | 0.9243 |
| 11:04 ET | 100 | 0.9243 |
| 11:06 ET | 100 | 0.9243 |
| 11:08 ET | 500 | 0.9239 |
| 11:09 ET | 7200 | 0.941 |
| 11:11 ET | 2300 | 0.9243 |
| 11:13 ET | 110 | 0.927 |
| 11:15 ET | 12432 | 0.9401 |
| 11:18 ET | 600 | 0.9298 |
| 11:20 ET | 4800 | 0.92145 |
| 11:22 ET | 4349 | 0.9298 |
| 11:24 ET | 3100 | 0.936125 |
| 11:26 ET | 4400 | 0.9408 |
| 11:27 ET | 9115 | 0.93125 |
| 11:29 ET | 9930 | 0.93125 |
| 11:31 ET | 3250 | 0.935375 |
| 11:33 ET | 2400 | 0.9307 |
| 11:36 ET | 598 | 0.9307 |
| 11:38 ET | 8500 | 0.92635 |
| 11:40 ET | 400 | 0.92635 |
| 11:42 ET | 1500 | 0.9312 |
| 11:44 ET | 3723 | 0.93075 |
| 11:45 ET | 4100 | 0.93 |
| 11:47 ET | 2394 | 0.92575 |
| 11:49 ET | 100 | 0.92575 |
| 11:51 ET | 3000 | 0.92575 |
| 11:54 ET | 2700 | 0.93075 |
| 11:56 ET | 1900 | 0.9299 |
| 11:58 ET | 4200 | 0.9218 |
| 12:00 ET | 2040 | 0.9305 |
| 12:02 ET | 920 | 0.92655 |
| 12:03 ET | 600 | 0.928 |
| 12:05 ET | 700 | 0.92055 |
| 12:07 ET | 2900 | 0.928 |
| 12:09 ET | 2100 | 0.928 |
| 12:12 ET | 36150 | 0.92705 |
| 12:14 ET | 200 | 0.92705 |
| 12:16 ET | 100 | 0.92705 |
| 12:18 ET | 3560 | 0.92655 |
| 12:20 ET | 1500 | 0.93 |
| 12:21 ET | 300 | 0.92655 |
| 12:27 ET | 8906 | 0.9245 |
| 12:30 ET | 2100 | 0.9311 |
| 12:32 ET | 5400 | 0.9311 |
| 12:34 ET | 243 | 0.9326 |
| 12:36 ET | 200 | 0.9397 |
| 12:38 ET | 600 | 0.9397 |
| 12:39 ET | 5400 | 0.92605 |
| 12:41 ET | 4400 | 0.9261 |
| 12:43 ET | 5600 | 0.9261 |
| 12:45 ET | 800 | 0.9215 |
| 12:48 ET | 6133 | 0.93 |
| 12:50 ET | 900 | 0.91995 |
| 12:52 ET | 850 | 0.9299 |
| 12:54 ET | 3229 | 0.926122 |
| 12:56 ET | 100 | 0.91495 |
| 12:57 ET | 650 | 0.91495 |
| 12:59 ET | 700 | 0.91495 |
| 01:01 ET | 4100 | 0.9299 |
| 01:03 ET | 600 | 0.91495 |
| 01:06 ET | 1243 | 0.915 |
| 01:08 ET | 100 | 0.91495 |
| 01:10 ET | 200 | 0.9153 |
| 01:12 ET | 600 | 0.9299 |
| 01:14 ET | 14700 | 0.93 |
| 01:15 ET | 11393 | 0.93 |
| 01:17 ET | 1986 | 0.9289 |
| 01:19 ET | 100 | 0.9203 |
| 01:21 ET | 7483 | 0.9145 |
| 01:26 ET | 4250 | 0.929 |
| 01:28 ET | 4800 | 0.929 |
| 01:30 ET | 300 | 0.9205 |
| 01:32 ET | 1100 | 0.9283 |
| 01:33 ET | 4993 | 0.9282 |
| 01:35 ET | 100 | 0.9211 |
| 01:37 ET | 900 | 0.929 |
| 01:39 ET | 4193 | 0.929 |
| 01:42 ET | 5100 | 0.92 |
| 01:44 ET | 200 | 0.92 |
| 01:46 ET | 2700 | 0.92 |
| 01:48 ET | 400 | 0.91 |
| 01:50 ET | 3300 | 0.92 |
| 01:51 ET | 100 | 0.9145 |
| 01:53 ET | 100 | 0.9175 |
| 01:55 ET | 200 | 0.9203 |
| 01:57 ET | 400 | 0.9145 |
| 02:00 ET | 6412 | 0.91 |
| 02:02 ET | 500 | 0.91 |
| 02:04 ET | 300 | 0.90515 |
| 02:06 ET | 400 | 0.91 |
| 02:08 ET | 2858 | 0.92025 |
| 02:11 ET | 1100 | 0.9135 |
| 02:13 ET | 13500 | 0.91 |
| 02:15 ET | 2500 | 0.9118 |
| 02:20 ET | 200 | 0.9192 |
| 02:26 ET | 900 | 0.9117 |
| 02:31 ET | 5200 | 0.9234 |
| 02:36 ET | 800 | 0.9234 |
| 02:38 ET | 600 | 0.923 |
| 02:44 ET | 4700 | 0.9145 |
| 02:45 ET | 7182 | 0.929 |
| 02:47 ET | 3100 | 0.9295 |
| 02:49 ET | 2200 | 0.91975 |
| 02:54 ET | 4003 | 0.929 |
| 02:56 ET | 100 | 0.92 |
| 02:58 ET | 4000 | 0.9294 |
| 03:00 ET | 2950 | 0.929 |
| 03:02 ET | 787 | 0.929 |
| 03:03 ET | 4600 | 0.929 |
| 03:05 ET | 300 | 0.9286 |
| 03:07 ET | 100 | 0.9283 |
| 03:09 ET | 1200 | 0.91945 |
| 03:12 ET | 3800 | 0.92915 |
| 03:14 ET | 1000 | 0.9095 |
| 03:16 ET | 3400 | 0.9194 |
| 03:18 ET | 1600 | 0.9263 |
| 03:20 ET | 4643 | 0.91 |
| 03:25 ET | 1250 | 0.9194 |
| 03:27 ET | 1219 | 0.9293 |
| 03:32 ET | 3713 | 0.92 |
| 03:36 ET | 2000 | 0.9144 |
| 03:38 ET | 8220 | 0.91 |
| 03:39 ET | 22053 | 0.91765 |
| 03:48 ET | 1300 | 0.9182 |
| 03:52 ET | 100 | 0.906 |
| 03:54 ET | 100 | 0.906 |
| 03:56 ET | 31306 | 0.929 |
| 03:57 ET | 14306 | 0.929 |
| 03:59 ET | 35226 | 0.93 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Allovir Inc | 102.2M | -0.8x | --- |
Regulus Therapeutics Inc | 102.1M | -1.2x | --- |
Fibrobiologics Inc | 103.7M | -3.2x | --- |
Genenta Science SPA | 97.2M | -7.3x | --- |
InflaRx NV | 92.4M | -1.8x | --- |
Relmada Therapeutics Inc | 105.6M | -1.2x | --- |
Company Information
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.
Contact Information
- Headquarters
- 1100 Winter StreetWALTHAM, MA, United States 02451
- Phone
- 617-433-2605
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- David Hallal
- President, Chief Financial Officer, Director
- Vikas Sinha
- Chief Executive Officer, Director
- Diana Brainard
- Co-Founder, Chief Scientific Officer
- Ann Leen
- Chief Accounting Officer
- Brett Hagen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $102.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 115.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-1.23 |
Book Value | $1.28 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
